Guy Salvesen

Guy Salvesen, Ph.D.[La Jolla]

  • Dean, Graduate School of Biomedical Sciences
  • Research

    Dr. Salvesen's research focuses on the central role of enzyme pathways in the intrinsic life span and death of cells.

  • Biography

    Dr. Salvesen earned his Ph.D. in biochemistry from Cambridge University in 1980.

Publications

 

View All Publications

Guy Salvesen's Research Focus

Cancer, Inflammatory/Autoimmune Disease, Neurodegenerative and Neuromuscular Diseases

The human body contains cells with different life expectancies. Some (white blood cells or skin, for example) are programmed to rapidly die and be replaced. Others (such as nerve cells) are programmed to survive the lifetime of the individual and are seldom replaced. Dr. Salvesen's research focuses on the central role enzyme pathways play in the life and death of cells. When death pathways slow down in cells that are normally programmed to die, cancer results. Conversely, when death pathways become overactive in cells that are programmed to survive, degenerative disease occurs. Dr. Salvesen's laboratory focuses on understanding the fundamental molecular interactions that occur within these enzyme pathways. This knowledge is used to engineer synthetic compounds to stimulate cell destruction in cancer cells, or delay cell destruction in neurodegenerative diseases and stroke.
 

Guy Salvesen's Research Report

Guy Salvesen

Structure and Function of Proteases and Their Natural Inhibitors

Our research seeks to delineate the structure --> activity --> function algorithm as it applies to proteases and their inhibitors. Our laboratory has very broad interests in principles of proteolysis in humans, and we take multi-pronged approaches to research on proteases and their inhibitors.


Apoptosis

In one approach we apply basic biochemical knowledge to investigate newly emerging principles of proteolysis in human systems. This research is currently dissecting the proteolytic components of the intracellular pathway that leads to apoptotic cell death. Programmed cell death monitors the growth of new cells and the elimination of old ones. This program contains a number of proteolytic steps that are essential for efficient execution of the death pathway. Thus the proteases of the pathway - the caspases - are involved in the normal maintenance of correct cell number, and are therefore implicated in a number of pathologic and physiologic conditions. Using the techniques of protein chemistry, enzymology, crystallography, and recombinant DNA methodologies, we analyze the basic mechanism utilized by caspases to promote cell death pathways, and the mechanisms and specificity of the natural inhibitors that control them.

The second BIR domain of X-linked Inhibitor of Apoptosis Protein (XIAP-green) binds into the substrate groove of caspase 3
















Caption: The second BIR domain of X-linked Inhibitor of Apoptosis Protein (XIAP-green) binds into the substrate groove of caspase 3, preventing access of a protein substrate and terminating apoptosis. (This representation is based on the PDB structure file 1I3O).


Cell Signaling

Modification of proteins by the small ubiquitin-like modifier SUMO is a dynamic and reversible process. The SUMO cycle begins when SUMO precursors are processed to remove short C-terminal extensions, thereby uncapping the C-terminal Gly-Gly motif that is essential for conjugation. SUMO ligases conjugate the protein, via its C-terminal carboxylate, to the side-chain lysine of target proteins to generate an isopeptide linkage. Eventually, SUMO is removed intact from its substrate SUMOylated proteins, and so the SUMOylation/deSUMOylation cycle regulates SUMOs function. A group of proteases known as SENPs are involved in both the activation of SUMO precursors (endopeptidase cleavage) and deconjugation of the targets (isopeptidase cleavage). Our laboratory is currently involved in projects to define the mechanisms that regulate SENP activity and access to their natural substrates.


Technology Development

The principle of proteolysis in vivo is to instigate irreversible changes to a set of protein substrates that alters their function and generates the required biological event. The sum total of the proteases and their target substrates operating in a physiologic pathway therefore defines the global event. Consequently, the identity of the substrate cleavages defines the proteases acting on them. We are developing proteomics-based methodologies, including selective protein labeling, multi-dimensional electrophoresis, and mass spectrometry techniques, to identify the products of proteolysis in vivo.

About Guy Salvesen

Experience

Guy Salvesen earned his Ph.D. in biochemistry from Cambridge University in 1980. He conducted postdoctoral research at Strangeways Laboratory and MRC Laboratory of Molecular Biology in Cambridge, followed by further post-doctoral training at the University of Georgia. In 1991 he was appointed Assistant Professor at Duke University. Dr. Salvesen was recruited to Sanford-Burnham Medical Research Institute in 1996, where he is professor and director of the Apoptosis and Cell Death Research Program and dean of the Graduate School of Biomedical Sciences. He also holds an adjunct position as professor in the Department of Pathology at the University of California, San Diego.

Upcoming Events
Become a Partner / Donate
Your support is crucial in turning hope into healing. Your support is crucial in turning hope into healing. Learn More
Social Media
Related to My Areas of Research
Education

Ph. D., University of Georgia, Athens, GA, Biochemistry, 1983
Ph. D., Cambridge University, England, Biology, 1981
B. Sc., London University, London, England, Microbiology, 1977

Other Appointments

Adjunct Professor, Department of Pathology, University of California, San Diego

Honors and Recognition

European Cell Death Organization Conference, Keynote Speaker, 2010
Gordon Research Conference on Cell Death, Keynote Speaker, 2010
Lifetime Achievement Award of the International Proteolysis Society, 2009
Queenstown Molecular Biology Conference, Keynote Speaker, 2008
Gordon Research Conference on Cell Death, Chair, 2008
Helmut Holzer Memorial Prize, 2005
International Proteolysis Society, Elected Secretary, 1999
Gordon Research Conference on Matrix Metalloproteinases, Keynote Speaker, 1999
American Association for the Study of Liver Diseases, State of the Art Lecture. 1988
Gordon Research Conference on Proteolytic Enzymes and their Inhibitors, Chair, 1996

Sign In Skip Navigation Links Skip navigation links
Our Mission
Research
Talent
Technology
Training & Education
Our Supporters
Privacy Policy